Filing Details
- Accession Number:
- 0001140361-17-002755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-24 19:58:45
- Reporting Period:
- 2017-01-20
- Filing Date:
- 2017-01-24
- Accepted Time:
- 2017-01-24 19:58:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1428336 | Healthequity Inc | HQY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1179972 | G Darcy Mott | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-20 | 14,000 | $0.10 | 70,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-20 | 4,612 | $47.40 | 65,388 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-20 | 5,388 | $48.02 | 60,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2017-01-20 | 14,000 | $0.00 | 14,000 | $0.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,000 | 2017-06-20 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $14.00 | 2024-07-30 | 10,000 | 10,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $0.10 | 2018-05-22 | 20,000 | 20,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $1.25 | 2021-08-08 | 125,000 | 125,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $25.39 | 2025-03-26 | 25,000 | 25,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-07-30 | 10,000 | 10,000 | Direct |
| 2018-05-22 | 20,000 | 20,000 | Direct |
| 2021-08-08 | 125,000 | 125,000 | Direct |
| 2025-03-26 | 25,000 | 25,000 | Direct |
Footnotes
- The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.13, inclusive.
- The option is immediately exercisable.
- The option became exercisable as to 6,250 shares on March 26, 2016. The remaining shares become exercisable in three equal annual installments of 6,250 shares on March 26, 2017, 2018 and 2019.
Billionaire Hedge Funds
